Market Access Strategies for the Global Healthcare Environment mktxs linkedin 1-908-864-4090
serv_2

 Portfolio Valuation

Assesses in-licensing or M&A opportunities to inform commercial decision-making.

Our Portfolio Valuation services integrate our core functionalities to assist manufacturers in the allocation of scarce resources.  MKTXS regularly engages our extensive Payer network to uncover access needs and potential barriers, and develops the substantiating market access strategies and health economic evidence to overcome the identified Payer hurdles.

The shift from pre-launch to pre-pivotal trial product valuation necessitates incorporation of the Payer perspective in the “go/no go” determination for commercial development. Through rigorous exploration of landscape and critical entry requirements, MKTXS prioritizes investment decision-making for pipeline development.

 

Sample MKTXS Engagements to Optimize an Assets Lifecycle Revenue

  • PHASE 1
    • Unmet needs analysis
    • Best label for reimbursement/patient access
    • Opportunity/asset assessment
    • Policy landscape evaluation
    • Evidence development & communication prioritization
  • PHASE 2
    • Unmet needs analysis
    • Best label for reimbursement/patient access
    • Opportunity/asset assessment
    • Policy landscape evaluation
    • Evidence development & communication prioritization
  • PHASE 3
    • Due diligence
    • Indication prioritization
    • Long-term strategic outlook and planning
  • PHASE 4
    • Due diligence
    • Indication prioritization
    • Long-term strategic outlook and planning
PHASE 1 PHASE 2 PHASE 3 PHASE 4